Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Gilead Sciences, Inc. (GILD) since 2015 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Gilead Sciences, Inc.. (See page 1 of this report.) Table 2 shows the detailed insider transactions. This company's CIK number is 882095.
Total stock buying since 2015: $999,150.
Total stock sales since 2015: $921,071,264.
Total stock option exercises since 2015: $235,428,585.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2025 | 0 | $0 | 571,542 | $62,026,245 | 558,111 | $29,850,886 |
| 2024 | 0 | $0 | 553,812 | $50,082,191 | 602,474 | $29,785,219 |
| 2023 | 0 | $0 | 32,096 | $2,551,890 | 146,531 | $442,191 |
| 2022 | 0 | $0 | 26,355 | $1,866,288 | 194,847 | $828,297 |
| 2021 | 0 | $0 | 66,560 | $4,452,843 | 172,673 | $1,756,865 |
| 2020 | 0 | $0 | 137,004 | $9,885,521 | 248,984 | $3,686,488 |
| 2019 | 0 | $0 | 128,408 | $8,418,483 | 159,162 | $2,742,587 |
| 2018 | 0 | $0 | 926,935 | $70,384,176 | 1,254,464 | $30,546,376 |
| 2017 | 0 | $0 | 1,447,128 | $107,862,022 | 1,498,305 | $32,405,995 |
| 2016 | 0 | $0 | 2,050,842 | $174,107,762 | 2,026,940 | $36,648,094 |
| 2015 | 10,000 | $999,150 | 4,020,793 | $429,433,843 | 3,952,353 | $66,735,587 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2015-08-03 | Carter Paul Rutherford (EVP Commercial Ops) | Option Ex | 5,000 | 26.99 | 134,950 |
| 2015-08-03 | Alton Gregg H (EVP, Corp & Med Affairs) | Sale | 17,000 | 119.25 | 2,027,250 |
| 2015-08-03 | Alton Gregg H (EVP, Corp & Med Affairs) | Option Ex | 15,000 | 23.75 | 356,325 |
| 2015-08-03 | Cogan John Francis | Sale | 15,000 | 120.00 | 1,800,000 |
| 2015-08-03 | Cogan John Francis | Option Ex | 15,000 | 20.70 | 310,575 |
| 2015-08-03 | Martin John C (Chairman and CEO) | Sale | 150,000 | 119.22 | 17,882,400 |
| 2015-08-03 | Martin John C (Chairman and CEO) | Option Ex | 150,000 | 14.50 | 2,175,450 |
| 2015-07-31 | Carter Paul Rutherford (EVP Commercial Ops) | Option Ex | 2,500 | .00 | 0 |
| 2015-07-15 | Bischofberger Norbert W (EVP, R&D and CSO) | Sale | 66,261 | 118.22 | 7,833,507 |
| 2015-07-15 | Bischofberger Norbert W (EVP, R&D and CSO) | Option Ex | 70,000 | 21.57 | 1,510,250 |
| 2015-07-07 | Milligan John F (President and COO) | Sale | 100,000 | 115.14 | 11,513,500 |
| 2015-07-07 | Milligan John F (President and COO) | Option Ex | 100,000 | 14.50 | 1,450,300 |
| 2015-07-07 | Bischofberger Norbert W (EVP, R&D and CSO) | Sale | 3,739 | 119.39 | 446,399 |
| 2015-07-01 | Carter Paul Rutherford (EVP Commercial Ops) | Sale | 3,000 | 118.24 | 354,729 |
| 2015-07-01 | Carter Paul Rutherford (EVP Commercial Ops) | Option Ex | 3,000 | 26.99 | 80,970 |
| 2015-07-01 | Alton Gregg H (EVP, Corp & Med Affairs) | Sale | 17,000 | 116.94 | 1,987,980 |
| 2015-07-01 | Alton Gregg H (EVP, Corp & Med Affairs) | Option Ex | 15,000 | 23.75 | 356,325 |
| 2015-07-01 | Martin John C (Chairman and CEO) | Sale | 150,000 | 117.00 | 17,549,700 |
| 2015-07-01 | Martin John C (Chairman and CEO) | Option Ex | 150,000 | 14.50 | 2,175,450 |
| 2015-06-26 | Cogan John Francis | Sale | 27,000 | 120.13 | 3,243,429 |
| 2015-06-26 | Cogan John Francis | Option Ex | 27,000 | 17.52 | 473,121 |
| 2015-06-18 | Carter Paul Rutherford (EVP Commercial Ops) | Sale | 10,000 | 120.00 | 1,200,030 |
| 2015-06-18 | Carter Paul Rutherford (EVP Commercial Ops) | Option Ex | 10,000 | 26.99 | 269,900 |
| 2015-06-15 | Bischofberger Norbert W (EVP, R&D and CSO) | Sale | 70,000 | 117.48 | 8,223,810 |
| 2015-06-15 | Bischofberger Norbert W (EVP, R&D and CSO) | Option Ex | 70,000 | 21.57 | 1,510,250 |
| 2015-06-08 | Milligan John F (President and COO) | Sale | 100,000 | 114.34 | 11,434,100 |
| 2015-06-08 | Milligan John F (President and COO) | Option Ex | 100,000 | 14.50 | 1,450,300 |
| 2015-06-01 | Carter Paul Rutherford (EVP Commercial Ops) | Sale | 3,000 | 113.09 | 339,279 |
| 2015-06-01 | Carter Paul Rutherford (EVP Commercial Ops) | Option Ex | 3,000 | 33.77 | 101,325 |
| 2015-06-01 | Alton Gregg H (EVP, Corp & Med Affairs) | Sale | 17,000 | 113.79 | 1,934,464 |
| 2015-06-01 | Alton Gregg H (EVP, Corp & Med Affairs) | Option Ex | 15,000 | 23.68 | 355,170 |
| 2015-06-01 | Martin John C (Chairman and CEO) | Sale | 150,000 | 113.77 | 17,065,050 |
| 2015-06-01 | Martin John C (Chairman and CEO) | Option Ex | 150,000 | 14.50 | 2,175,450 |
| 2015-05-15 | Carter Paul Rutherford (EVP Commercial Ops) | Sale | 6,000 | 110.00 | 660,018 |
| 2015-05-15 | Carter Paul Rutherford (EVP Commercial Ops) | Option Ex | 6,000 | 60.60 | 363,630 |
| 2015-05-15 | Alton Gregg H (EVP, Corp & Med Affairs) | Sale | 25,000 | 110.01 | 2,750,200 |
| 2015-05-15 | Alton Gregg H (EVP, Corp & Med Affairs) | Option Ex | 25,000 | 21.34 | 533,575 |
| 2015-05-15 | Bischofberger Norbert W (EVP, R&D and CSO) | Sale | 70,000 | 109.38 | 7,656,810 |
| 2015-05-15 | Bischofberger Norbert W (EVP, R&D and CSO) | Option Ex | 70,000 | 21.16 | 1,481,060 |
| 2015-05-10 | Carter Paul Rutherford (EVP Commercial Ops) | Option Ex | 5,000 | .00 | 0 |
| 2015-05-07 | Milligan John F (President and COO) | Sale | 100,000 | 101.12 | 10,111,800 |
| 2015-05-07 | Milligan John F (President and COO) | Option Ex | 100,000 | 14.50 | 1,450,300 |
| 2015-05-05 | Whitley Richard James | Option Ex | 23,624 | 9.81 | 231,869 |
| 2015-05-05 | Cogan John Francis | Option Ex | 1,904 | .00 | 0 |
| 2015-05-05 | Wilson Gayle E | Option Ex | 1,904 | .00 | 0 |
| 2015-05-05 | Davignon Etienne | Option Ex | 1,904 | .00 | 0 |
| 2015-05-05 | Hills Carla A | Option Ex | 1,904 | .00 | 0 |
| 2015-05-05 | Wold Olsen Per | Option Ex | 1,904 | .00 | 0 |
| 2015-05-05 | Madigan John W | Option Ex | 1,904 | .00 | 0 |
| 2015-05-01 | Carter Paul Rutherford (EVP Commercial Ops) | Sale | 2,000 | 103.18 | 206,366 |
| 2015-05-01 | Carter Paul Rutherford (EVP Commercial Ops) | Option Ex | 2,000 | 80.65 | 161,300 |
| 2015-05-01 | Alton Gregg H (EVP, Corp & Med Affairs) | Sale | 12,000 | 104.77 | 1,257,240 |
| 2015-05-01 | Alton Gregg H (EVP, Corp & Med Affairs) | Option Ex | 10,000 | 19.09 | 190,850 |
| 2015-05-01 | Washington Robin L (EVP, CFO) | Sale | 16,842 | 104.77 | 1,764,452 |
| 2015-05-01 | Washington Robin L (EVP, CFO) | Option Ex | 16,842 | 32.43 | 546,152 |
| 2015-05-01 | Martin John C (Chairman and CEO) | Sale | 150,000 | 104.66 | 15,699,000 |
| 2015-05-01 | Martin John C (Chairman and CEO) | Option Ex | 150,000 | 14.50 | 2,175,450 |
| 2015-04-15 | Bischofberger Norbert W (EVP, R&D and CSO) | Sale | 70,000 | 103.52 | 7,246,050 |
| 2015-04-15 | Bischofberger Norbert W (EVP, R&D and CSO) | Option Ex | 70,000 | 20.74 | 1,451,800 |
| 2015-04-08 | Carter Paul Rutherford (EVP Commercial Ops) | Sale | 1,000 | 100.00 | 100,000 |
| 2015-04-08 | Carter Paul Rutherford (EVP Commercial Ops) | Option Ex | 1,000 | 80.65 | 80,650 |
| 2015-04-08 | Alton Gregg H (EVP, Corp & Med Affairs) | Sale | 5,000 | 100.00 | 500,000 |
| 2015-04-08 | Alton Gregg H (EVP, Corp & Med Affairs) | Option Ex | 5,000 | 19.09 | 95,425 |
| 2015-04-01 | Carter Paul Rutherford (EVP Commercial Ops) | Sale | 1,000 | 98.04 | 98,044 |
| 2015-04-01 | Carter Paul Rutherford (EVP Commercial Ops) | Option Ex | 1,000 | 80.65 | 80,650 |
| 2015-04-01 | Alton Gregg H (EVP, Corp & Med Affairs) | Sale | 7,000 | 96.70 | 676,872 |
| 2015-04-01 | Alton Gregg H (EVP, Corp & Med Affairs) | Option Ex | 5,000 | 19.09 | 95,425 |
| 2015-04-01 | Martin John C (Chairman and CEO) | Sale | 150,000 | 97.12 | 14,568,750 |
| 2015-04-01 | Martin John C (Chairman and CEO) | Option Ex | 150,000 | 14.50 | 2,175,450 |
| 2015-03-16 | Bischofberger Norbert W (EVP, R&D and CSO) | Sale | 70,000 | 100.77 | 7,053,830 |
| 2015-03-16 | Bischofberger Norbert W (EVP, R&D and CSO) | Option Ex | 70,000 | 18.57 | 1,299,760 |
| 2015-03-02 | Carter Paul Rutherford (EVP Commercial Ops) | Sale | 2,000 | 104.18 | 208,364 |
| 2015-03-02 | Carter Paul Rutherford (EVP Commercial Ops) | Option Ex | 2,000 | 80.65 | 161,300 |
| 2015-03-02 | Whitley Richard James | Sale | 5,000 | 103.43 | 517,135 |
| 2015-03-02 | Whitley Richard James | Option Ex | 5,000 | 26.99 | 134,950 |
| 2015-03-02 | Alton Gregg H (EVP, Corp & Med Affairs) | Sale | 12,000 | 103.82 | 1,245,840 |
| 2015-03-02 | Alton Gregg H (EVP, Corp & Med Affairs) | Option Ex | 10,000 | 19.09 | 190,850 |
| 2015-03-02 | Martin John C (Chairman and CEO) | Sale | 150,000 | 103.51 | 15,526,200 |
| 2015-03-02 | Martin John C (Chairman and CEO) | Option Ex | 150,000 | 14.50 | 2,175,450 |
| 2015-03-01 | Moore Nicholas G | Option Ex | 167 | .00 | 0 |
| 2015-02-17 | Bischofberger Norbert W (EVP, R&D and CSO) | Sale | 70,000 | 102.96 | 7,207,130 |
| 2015-02-17 | Bischofberger Norbert W (EVP, R&D and CSO) | Option Ex | 70,000 | 16.39 | 1,147,650 |
| 2015-02-06 | Wold Olsen Per | Buy | 10,000 | 99.92 | 999,150 |
| 2015-02-02 | Carter Paul Rutherford (EVP Commercial Ops) | Sale | 2,000 | 106.16 | 212,310 |
| 2015-02-02 | Carter Paul Rutherford (EVP Commercial Ops) | Option Ex | 2,000 | 80.65 | 161,300 |
| 2015-02-02 | Whitley Richard James | Sale | 5,000 | 106.01 | 530,030 |
| 2015-02-02 | Whitley Richard James | Option Ex | 5,000 | 26.99 | 134,950 |
| 2015-02-02 | Alton Gregg H (EVP, Corp & Med Affairs) | Sale | 12,000 | 105.98 | 1,271,808 |
| 2015-02-02 | Alton Gregg H (EVP, Corp & Med Affairs) | Option Ex | 10,000 | 19.09 | 190,850 |
| 2015-02-02 | Washington Robin L (EVP, CFO) | Sale | 33,192 | 105.99 | 3,518,020 |
| 2015-02-02 | Washington Robin L (EVP, CFO) | Option Ex | 33,192 | 26.92 | 893,661 |
| 2015-02-02 | Martin John C (Chairman and CEO) | Sale | 150,000 | 105.98 | 15,896,550 |
| 2015-02-02 | Martin John C (Chairman and CEO) | Option Ex | 150,000 | 14.50 | 2,175,450 |
| 2015-01-15 | Bischofberger Norbert W (EVP, R&D and CSO) | Sale | 70,000 | 98.73 | 6,911,380 |
| 2015-01-15 | Bischofberger Norbert W (EVP, R&D and CSO) | Option Ex | 70,000 | 16.39 | 1,147,650 |
| 2015-01-08 | Carter Paul Rutherford (EVP Commercial Ops) | Sale | 1,000 | 100.88 | 100,881 |
| 2015-01-08 | Carter Paul Rutherford (EVP Commercial Ops) | Option Ex | 1,000 | 33.77 | 33,775 |
| 2015-01-08 | Alton Gregg H (EVP, Corp & Med Affairs) | Sale | 5,000 | 100.89 | 504,450 |
| 2015-01-08 | Alton Gregg H (EVP, Corp & Med Affairs) | Option Ex | 5,000 | 19.09 | 95,425 |
| 2015-01-05 | Martin John C (Chairman and CEO) | Sale | 100 | 96.65 | 9,665 |
| 2015-01-02 | Carter Paul Rutherford (EVP Commercial Ops) | Sale | 1,000 | 95.05 | 95,050 |
| 2015-01-02 | Carter Paul Rutherford (EVP Commercial Ops) | Option Ex | 1,000 | 40.56 | 40,560 |
| 2015-01-02 | Whitley Richard James | Sale | 5,000 | 95.50 | 477,480 |
| 2015-01-02 | Whitley Richard James | Option Ex | 5,000 | 26.99 | 134,950 |
| 2015-01-02 | Alton Gregg H (EVP, Corp & Med Affairs) | Sale | 7,000 | 95.53 | 668,682 |
| 2015-01-02 | Alton Gregg H (EVP, Corp & Med Affairs) | Option Ex | 5,000 | 19.09 | 95,425 |
| 2015-01-02 | Martin John C (Chairman and CEO) | Sale | 149,900 | 95.46 | 14,309,753 |
| 2015-01-02 | Martin John C (Chairman and CEO) | Option Ex | 150,000 | 14.50 | 2,175,450 |
Insider trading activities including stock purchases, stock sales, and option exercises of GILD listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Gilead Sciences, Inc. (symbol GILD, CIK number 882095) see the Securities and Exchange Commission (SEC) website.